CHICAGO & BARCELONA, Spain--(BUSINESS WIRE)--At the European Association of Nuclear Medicine (EANM) Annual Meeting, GE Healthcare proudly introduces Omni Legend i, the first system on its all-new, all ...
Zacks Investment Research on MSN
SGHT Shares Rise on Meta-Analysis Showing OMNI's Long-Term Benefits
Sight Sciences SGHT recently announced the publication of a systematic literature review and meta-analysis in the European ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A study looked at real-world outcomes with Omni, Hydrus, ...
Sight Sciences today announced new clinical data supporting its Omni minimally invasive glaucoma surgery (MIGS) device.
Sight Sciences Inc. (NASDAQ:SGHT) on Tuesday announced that UnitedHealthcare has updated its Glaucoma Surgical Treatments policy to cover goniotomy, trabeculotomy, canaloplasty (ab interno), and ...
Compendium of clinical presentations includes studies with up to 3.5 years of patient follow-up and over 400 eyes treated in 31 centers in both combination cataract and standalone use MENLO PARK, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback